AAAAAA

   
Results: 1-9 |
Results: 9

Authors: Kauschke, E Komiyama, K Moro, I Eue, I Konig, S Cooper, EL
Citation: E. Kauschke et al., Evidence for perforin-like activity associated with earthworm leukocytes, ZOOL-AN COM, 104(1), 2001, pp. 13-24

Authors: Eue, I Sorg, C
Citation: I. Eue et C. Sorg, Arachidonic acid specifically regulates binding of S100A8/A9, a heterodimer complex of the S100 class of calcium binding proteins, to human microvascular endothelial cells, ATHEROSCLER, 154(2), 2001, pp. 505-508

Authors: Eue, I
Citation: I. Eue, Growth inhibition of human mammary carcinoma by liposomal hexadecylphosphocholine: Participation of activated macrophages in the antitumor mechanism, INT J CANC, 92(3), 2001, pp. 426-433

Authors: Eue, I Pietz, B Storck, J Klempt, M Sorg, C
Citation: I. Eue et al., Transendothelial migration of 27E10(+) human monocytes, INT IMMUNOL, 12(11), 2000, pp. 1593-1604

Authors: Kumar, R Xie, KP Eue, I Dong, ZY Killion, JJ Fidler, IJ
Citation: R. Kumar et al., Differential regulation of type IV collagenases and metalloelastase in murine macrophages by the synthetic bacterial lipopeptide JBT 3002, INT J IMMUN, 22(6), 2000, pp. 431-443

Authors: Zak, J Schneider, SW Eue, I Ludwig, T Oberleithner, H
Citation: J. Zak et al., High-resistance MDCK-C7 monolayers used for measuring invasive potency of tumour cells, PFLUG ARCH, 440(1), 2000, pp. 179-183

Authors: Eue, I Langer, C von Eckardstein, A Sorg, C
Citation: I. Eue et al., Myeloid related protein (MRP) 14 expressing monocytes infiltrate atherosclerotic lesions of ApoE null mice, ATHEROSCLER, 151(2), 2000, pp. 593-597

Authors: Kerkhoff, C Eue, I Sorg, C
Citation: C. Kerkhoff et al., The regulatory role of MRP8 (S100A8) and MRP14 (S100A9) in the transendothelial migration of human leukocytes, PATHOBIOLOG, 67(5-6), 1999, pp. 230-232

Authors: Dong, ZY Greene, G Pettaway, C Dinney, CPN Eue, I Lu, WX Bucana, CD Balbay, MD Bielenberg, D Fidler, IJ
Citation: Zy. Dong et al., Suppression of angiogenesis, tumorigenicity, and metastasis by human prostate cancer cells engineered to produce interferon-beta, CANCER RES, 59(4), 1999, pp. 872-879
Risultati: 1-9 |